These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 13628822)

  • 1. Behavior of total serum complement in Hodgkin's disease and other malignant lymphomas.
    ROTTINO A; LEVY AL
    Blood; 1959 Mar; 14(3):246-54. PubMed ID: 13628822
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum proteins in Hodgkin's disease and malignant lymphoma.
    ARENDS T; COONRAD EV; RUNDLES RW
    Am J Med; 1954 Jun; 16(6):833-41. PubMed ID: 13158372
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum ceruloplasmin levels in Hodgkin's disease and malignant lymphomas in correlation with serum copper levels.
    Sirsat AV; Raste AS; Talavdekar RV; Advani SH
    Indian J Cancer; 1979 Jun; 16(2):32-4. PubMed ID: 546729
    [No Abstract]   [Full Text] [Related]  

  • 4. Discriminant analysis of Hodgkin's disease and non-Hodgkin's lymphomas by age and serum proteins.
    Merucci P; Taggi F; Marolla A; Abbolito MR; Vitelli G; Marolla P; Meliffi L; Chiarotti F; Ippolito FM; Ameglio F
    Eur J Cancer Clin Oncol; 1984 Oct; 20(10):1243-7. PubMed ID: 6567527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum copper, serum ceruloplasmin, and erythrocyte sedimentation rate measurements in children with Hodgkin's disease, non-Hodgkin's lymphoma, and nonmalignant lymphadenopathy.
    Margerison AC; Mann JR
    Cancer; 1985 Apr; 55(7):1501-6. PubMed ID: 3978543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum ceruloplasmin levels in patients of leukaemias, Hodgkin's and non-Hodgkin's lymphomas.
    Aggarwal AK; Sanwalka AB; Vadehra PL; Prabhakar BR
    Indian J Pathol Microbiol; 1984 Oct; 27(4):347-52. PubMed ID: 6534868
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serumferritin in patients with malignant lymphomas (author's transl)].
    Oertel J; Schultz E; Korinth E; Heilhecker A
    Klin Wochenschr; 1977 Nov; 55(22):1109-14. PubMed ID: 592680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum citric acid in Hodgkin's disease, lymphoma and carcinoma.
    ROTTINO A; HOFFMANN GT; BRONDOLO B
    Proc Soc Exp Biol Med; 1952 Jun; 80(2):339-41. PubMed ID: 14949044
    [No Abstract]   [Full Text] [Related]  

  • 9. Superoxide anion (O-2) production by peripheral blood monocytes in Hodgkin's disease and malignant lymphoma.
    Perez-Soler R; Lopez-Berestein G; Cabanillas F; McLaughlin P; Hersh EM
    J Clin Oncol; 1985 May; 3(5):641-5. PubMed ID: 2987422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of vimentin and epithelial membrane antigen in human malignant lymphomas.
    Sarker AB; Akagi T; Yoshino T; Hoshida Y; Takahashi K; Horie Y
    Acta Pathol Jpn; 1990 Aug; 40(8):581-7. PubMed ID: 2239313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasma hemostasis disorders in Hodgkin's disease and non-Hodgkin's lymphoma].
    Zawilska K; Psuja P; Komarnicki M; Sowier J; Wysocki K
    Pol Arch Med Wewn; 1981 Aug; 66(2):123-31. PubMed ID: 7322926
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemical markers in Hodgkin's disease and non-Hodgkin's lymphoma.
    Child JA; Cooper EH; Illingworth S; Worthy TS
    Recent Results Cancer Res; 1978; 64():180-9. PubMed ID: 366696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocytic characterization in Hodgkin's and non-Hodgkin's lymphoma.
    Kamthan M; Joshi N; Sharma ML
    Indian J Pathol Microbiol; 1982 Apr; 25(2):139-43. PubMed ID: 6982850
    [No Abstract]   [Full Text] [Related]  

  • 14. DNA synthesis in unstimulated blood lymphocytes of patients with untreated malignant lymphomas or other malignant tumors.
    Heier HE; Godal T
    Scand J Haematol; 1977 Feb; 18(2):149-53. PubMed ID: 320650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential benefits of therapeutic splenectomy for patients with Hodgkin's disease and non-Hodgkin's lymphomas.
    Schreiber DP; Jacobs C; Rosenberg SA; Cox RS; Hoppe RT
    Int J Radiat Oncol Biol Phys; 1985 Jan; 11(1):31-6. PubMed ID: 3838166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of in vitro irradiation on mitogenic responsiveness of peripheral blood lymphocytes from untreated patients with Hodgkin's disease and non-Hodgkin's lymphoma.
    Rotstein S; Baral E; Blomgren H; Johansson B
    Cancer; 1982 Sep; 50(5):900-3. PubMed ID: 7093927
    [No Abstract]   [Full Text] [Related]  

  • 17. Elevation of serum polyamines in malignant lymphomas and acute myeloid leukemia.
    Hospattankar AV; Advani SH; Vaidya NR; Electricwalla SE; Braganca BM
    Int J Cancer; 1980 Apr; 25(4):463-6. PubMed ID: 6929272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of plasma levels in malignant lymphoma.
    Opat P; Rejthar A; Tomanová J; Trnka A; Wotke R
    Neoplasma; 1981; 28(3):339-43. PubMed ID: 7290261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of immunoglobulin production by tumor cells in non-Hodgkin's and Hodgkin's malignant lymphomas and its significance for their classification.
    Stein H; Papadimitriou CS; Bouman H; Lennert K; Fuchs J
    Recent Results Cancer Res; 1978; 64():158-75. PubMed ID: 366694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of ceruloplasmin, properdin factor B and copper in lymphoma patients.
    Casamassima A; Addabbo L; Caporusso L; Lorusso V
    Int J Biol Markers; 1991; 6(3):183-7. PubMed ID: 1791312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.